NirmishSinglaMDMSCS

Minimally Invasive Surgery, Surgical Oncology

Urologic Oncologist/Surgeon at Johns Hopkins | Director of Translational Research in GU Oncology | Director, Kidney & Testicular Cancer Programs | Co-Director, UTUC Multidisciplinary Clinic | Vice Chair, Quality & Safety

Join to view full profile

Dr. Singla is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Singla's full profile

Already have an account?

Office
10803 Falls Road
Pavilion Iii Ste 3300
Lutherville, MD 21093
Phone+1 410-955-6100

Fax+1 410-616-7601

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2019 - 2020
University of Texas Southwestern Medical CenterFellowship, Physician Administrative Fellow, 2018 - 2019
University of Texas M.D. Anderson Cancer CenterPost-Doctoral Fellowship, 2018 - 2019
University of Texas Southwestern Medical CenterMSCS, Master of Science in Clinical Science, 2018 - 2019
University of Texas Southwestern Medical CenterChief Residency, Urology, 2017 - 2018
University of Texas Southwestern Medical CenterResidency, Urology, 2014 - 2018
University of Texas Southwestern Medical CenterInternship, Surgery, 2013 - 2014
University of Michigan Medical SchoolClass of 2013, MD
University of MichiganBSE, Biomedical Engineering, 2006 - 2009

Certifications & Licensure

MD State Medical License 2020 - 2025
NH State Medical License 2024 - 2024
TX State Medical License 2018 - 2021
NY State Medical License 2018 - 2020
American Board of Urology Urology

Publications & Presentations

PubMed

Primary retroperitoneal lymph node dissection in clinical stage 2a/b non-seminomatous germ cell tumour.
Luca Antonelli, Axel Heidenreich, Aditya Bagrodia, Armon Amini, Fady Baky
BJU International. 2025-04-01
Multi-institutional Analysis of Immune-Oncology Combination Therapy for Metastatic MiT Family Translocation Renal Cell Carcinoma.
Yasser Ged, Amina Touma, Luis Meza Contreras, Roy Elias, Joseph Van Galen
Journal of Immunotherapy. 2025-04-01
Clear cell renal cell carcinoma molecular subtypes differ by African and European genetic similarity groups.
Roy Elias, Thomas Nirschl, Michael Rezaee, Anirudh Yerrapragada, Shirley Wang
Cancer Research Communications. 2025-03-25

Lectures

Unraveling the molecular profile underpinning pancreatic tropisms in metastatic clear cell renal cell carcinoma.
2019 ASCO Annual Meeting - 6/1/2019
Leveraging a robust patient-derived xenograft platform to characterize predictors for engraftment and oncologic outcomes in renal cell carcinoma patients.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Prostate Cancer Consensus Conference Offers Guide to Clinical DilemmasJanuary 10th, 2023
Immunotherapy Enables Nephrectomy with Good Outcomes in Advanced RCCOctober 21st, 2019
Urology Mentors: For Many, the Quest Begins at HomeJanuary 8th, 2016